We aimed to present a unique case of a child with an optic disc granuloma with exudative retinal detachment as a manifestation of ocular toxocariasis. The response to systemic therapy was assessed using deep range imaging optical coherence tomography. This imaging technique was the most accurate for identification of retinal, macular and vitreous changes associated with this intraocular pathology.

Toxocariasis is a globally prevalent illness caused by infestation of larvae of the parasite Toxocara canis or Toxocara cati, which is the most ubiquitous gastrointestinal helminth in dogs and cats, respectively [1]. Human infection is due to accidental ingestion of infective eggs and tissue invasion of migrating parasitic larvae. Symptoms of the infection depend on the involved organs [2, 3]. Larvae that migrate to the eye cause ocular toxocariasis (OT). The average age at diagnosis of OT is 7.5 years (ranging from 2 to 31 years) and 80% of the patients are younger than 16 years [4]. The most common symptoms and signs of OT are decreased vision, strabismus, leukocoria, peripheral or posterior pole retinal granuloma, and chronic endophthalmitis [1, 4].

We present the case of an optic disc granuloma with exudative retinal detachment as a manifestation of OT. The response to systemic therapy was assessed using deep range imaging optical coherence tomography (DRI-OCT). To our knowledge there are few reports of DRI-OCT findings in OT and only two presenting this parasitic disease as a granuloma overlying the optic disc [5-9].

A generally healthy 5-year-old boy with no known ophthalmological history was evaluated for leukocoria and decreased visual acuity in the right eye (RE). Ophthalmic examination revealed a best corrected visual acuity in the left eye of 6/6, and only light perception with projection in the RE. The slit lamp examination showed no abnormalities. Indirect ophthalmoscopy of the RE revealed exudative retinal detachment and a large, white, and well-circumscribed mass overlying the optic disc (Fig. 1a). Sporadic inflammatory cells in the vitreous body were present. No abnormalities were found in the left eye.

Fig. 1.

a Fundus image (mosaic) of the right eye showing a well-defined, creamy, and well-circumscribed mass overlying the optic disc with a net of superficial vessels and surrounding serous retinal detachment. b B-scan ultrasound image of the right eye demonstrating an oval-shaped, medium-reflectivity mass overlying the optic disc with adjacent retinal detachment. Mild vitritis is present. c Deep range imaging optical coherence tomography (DRI-OCT) image of the right eye showing an oval-shaped lesion/cyst (450 × 250 µm) with low reflectivity and well-demarcated borders (blue arrowheads), surrounded by subretinal fluid. Within the lesion, the internal layers present high reflectivity, with an area of low reflectivity beneath, which did not allow any exact visualization of the external retinal layers surrounding the optic disc. Inflammatory cells (vitritis) and inflammatory membranes adhesive to the surface of the lesion with vitreoretinal traction are present (red arrows). d Fundus image (mosaic) of the right eye at the 12-month follow-up showing complete resolution of the lesion; the pale optic disc is now visible, surrounded by hard exudates and remnants of fibrous tissue. Single fibrous subretinal proliferations around the optic disc are also present. The macula presents retinal pigment epithelium alterations (hypo- and hyperpigmentation changes). e B-scan ultrasound image of the right eye demonstrating significant lesion regression with no serous retinal detachment. f DRI-OCT image of the right eye showing posterior vitreous detachment with localized condensed vitreous opacities (blue arrowheads) and only few inflammatory cells on the surface of the lesion. The reduction of the granuloma size makes the choroid and retinal pigment epithelium visible. No subretinal fluid is observed. The retina near the lesion shows edema and alterations of the epiretinal membrane and retinal pigment epithelium (red arrows).

Fig. 1.

a Fundus image (mosaic) of the right eye showing a well-defined, creamy, and well-circumscribed mass overlying the optic disc with a net of superficial vessels and surrounding serous retinal detachment. b B-scan ultrasound image of the right eye demonstrating an oval-shaped, medium-reflectivity mass overlying the optic disc with adjacent retinal detachment. Mild vitritis is present. c Deep range imaging optical coherence tomography (DRI-OCT) image of the right eye showing an oval-shaped lesion/cyst (450 × 250 µm) with low reflectivity and well-demarcated borders (blue arrowheads), surrounded by subretinal fluid. Within the lesion, the internal layers present high reflectivity, with an area of low reflectivity beneath, which did not allow any exact visualization of the external retinal layers surrounding the optic disc. Inflammatory cells (vitritis) and inflammatory membranes adhesive to the surface of the lesion with vitreoretinal traction are present (red arrows). d Fundus image (mosaic) of the right eye at the 12-month follow-up showing complete resolution of the lesion; the pale optic disc is now visible, surrounded by hard exudates and remnants of fibrous tissue. Single fibrous subretinal proliferations around the optic disc are also present. The macula presents retinal pigment epithelium alterations (hypo- and hyperpigmentation changes). e B-scan ultrasound image of the right eye demonstrating significant lesion regression with no serous retinal detachment. f DRI-OCT image of the right eye showing posterior vitreous detachment with localized condensed vitreous opacities (blue arrowheads) and only few inflammatory cells on the surface of the lesion. The reduction of the granuloma size makes the choroid and retinal pigment epithelium visible. No subretinal fluid is observed. The retina near the lesion shows edema and alterations of the epiretinal membrane and retinal pigment epithelium (red arrows).

Close modal

The patient was imaged with DRI-OCT (Atlantis; Topcon, Japan), ultrasonography, and magnetic resonance imaging of the orbits (Fig. 1b, c). The complete blood count and C-reactive protein levels were normal. Toxoplasma and viral serology findings were negative (CMV, HSV, VZV, EBV, HCV, and HBV). Toxocara IgG antibodies detected in serum with the ELISA method were positive (IgG 35.77 NTU). The chest X-ray image and computed tomography scan of the brain were normal. Stool ovum and parasite tests were negative. The patient’s mother did not provide written consent for a diagnostic biopsy of the vitreous body. The patient was diagnosed with OT and treated with albendazole 400 mg twice a day for 4 weeks and systemic corticosteroids with a loading dose of 1 mg/kg/day and then tapering.

After 1 year of follow-up, the fundus examination, DRI-OCT, and ultrasonography scans showed significant lesion regression with optic disc granuloma scarring and no serous retinal detachment (Fig. 1d–f). The vision of the RE improved up to 6/20.

At the baseline examination, DRI-OCT showed inflammatory cells in the vitreous body and vitreoretinal tractions at the granuloma-vitreous interface. Within the lesion, the internal layers presented a homogeneous high-reflectivity mass with many hyperreflectivity spots, which may have been related to eosinophil infiltration. The presence of this lesion did not allow for any exact visualization of the external retinal layers surrounding the optic disc (shadow effect). Retinal detachment was detected around the granuloma (Fig. 1c).

One year after the diagnosis and treatment, DRI-OCT of the RE showed posterior vitreous detachment with localized condensed vitreous opacities and only few inflammatory cells on the surface of the lesion. The reduction of the granuloma size made the choroid and retinal pigment epithelium visible. No subretinal fluid was observed. The retina near to the lesion showed edema as well as alterations of the epiretinal membrane and retinal pigment epithelium (Fig. 1f).

In most cases, it is difficult to establish the diagnosis of OT based on clinical manifestations only, because ocular symptoms may be various and inflammatory signs are not always present [1-4] and this clinical entity may be confused with retinoblastoma in children. Due to the potentially profound significance of misdiagnosis, very careful examination should be performed. The presumptive diagnosis of OT is generally based on a history of geophagia, contact with dogs, and laboratory findings; however, serological tests may be negative [10]. Due to the fact that the clinical signs of OT are not specific, a differential diagnosis should consider other parasitic diseases, other causes of posterior uveitis, and the possible occurrence of retinoblastoma in childhood. Laboratory tests include the detection of specific IgG in the serum (ELISA, 90% specificity, 91% sensitivity) or intraocular fluids [1, 2, 10]. However, approximately 10% of patients with clinical signs of OT present negative results with the ELISA method from ocular fluid samples [10].

In the present case, we would like to underline the value of a noninvasive imaging method (DRI-OCT) in the diagnosis and evaluation of toxocara optic disc granuloma in children. Our findings are in accordance with other publications. Several authors have shown that Toxocara granuloma is associated with vitreous opacities as a sign of inflammation and may induce vitreous traction, macular edema, and epiretinal membrane formation [5-9].

In our opinion, the use of DRI-OCT was the most adequate noninvasive imaging method for assessment of the evolution of retinal changes, vitreous traction, and signs of vitritis during the follow-up period and for analyzing the response of the optic disc granuloma to therapy. DRI-OCT imaging may offer a simple and practical diagnostic tool for the evaluation of posterior pole lesions due to OT.

The authors have no ethical conflicts to disclose. Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

The authors have no conflicts of interest to disclose. None of the authors has any financial disclosure to make relevant to this manuscript.

1.
Rubinsky-Elefant
G
,
Hirata
CE
,
Yamamoto
JH
,
Ferreira
MU
.
Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms
.
Ann Trop Med Parasitol
.
2010
Jan
;
104
(
1
):
3
23
.
[PubMed]
0003-4983
2.
Martínez-Pulgarín
DF
,
Muñoz-Urbano
M
,
Gomez-Suta
LD
,
Delgado
OM
,
Rodriguez-Morales
AJ
.
Ocular toxocariasis: new diagnostic and therapeutic perspectives
.
Recent Pat Antiinfect Drug Discov
.
2015
;
10
(
1
):
35
41
.
[PubMed]
2212-4071
3.
Macpherson
CN
.
The epidemiology and public health importance of toxocariasis: a zoonosis of global importance
.
Int J Parasitol
.
2013
Nov
;
43
(
12-13
):
999
1008
.
[PubMed]
0020-7519
4.
Arevalo
JF
,
Espinoza
JV
,
Arevalo
FA
.
Ocular toxocariasis
.
J Pediatr Ophthalmol Strabismus
.
2013
Mar-Apr
;
50
(
2
):
76
86
.
[PubMed]
0191-3913
5.
Hashida
N
,
Nakai
K
,
Nishida
K
.
Diagnostic evaluation of ocular toxocariasis using high-penetration optical coherence tomography
.
Case Rep Ophthalmol
.
2014
Jan
;
5
(
1
):
16
21
.
[PubMed]
1663-2699
6.
Verallo
O
,
Fragiotta
S
,
Verboschi
F
,
Vingolo
EM
.
Diagnostic aspects and retinal imaging in ocular toxocariasis: a case report from Italy
.
Case Rep Med
.
2012
;
2012
:
984512
.
[PubMed]
1687-9627
7.
Kim
YJ
,
Moon
CH
,
Chang
JH
.
Toxocariasis of the optic disc
.
J Neuroophthalmol
.
2013
Jun
;
33
(
2
):
151
2
.
[PubMed]
1070-8022
8.
Chelnis
J
,
Selvadurai
AD
,
Fasiuddin
A
.
Enhanced depth imaging and fundus autofluorescence of Toxocara optic nerve granuloma
.
Ocul Immunol Inflamm
.
2013
;
21
(
1
):
82
3
.
[PubMed]
0927-3948
9.
Carvalho da Silva
FT
,
Yamamoto
JH
,
Hirata
CE
,
Nakashima
Y
,
Chieffi
PP
,
Olivalves
E
.
Optical coherence tomography of a subretinal granuloma in simultaneous visceral and ocular larva migrans
.
Retin Cases Brief Rep
.
2008
;
2
(
4
):
316
8
.
[PubMed]
1935-1089
10.
Ahn
SJ
,
Ryoo
NK
,
Woo
SJ
.
Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention
.
Asia Pac Allergy
.
2014
Jul
;
4
(
3
):
134
41
.
[PubMed]
2233-8276
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.